WHO warns 2022 financial support for malaria R&D was lowest it’s been for 15 years
Funding for malaria R&D dropped for the fourth year in a row in 2022, hitting the lowest it’s been for 15 years, the World Health Organization has said.
The WHO’s World Malaria Report, published on 30 November, says US$603 million was spent on malaria R&D globally last year, a 10 per cent drop from 2021. Malaria R&D funds rose slowly before their peak in 2018, while the last four years of decline has been steep.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.